Therapeutic Advances in Biological Response Modifiers in the Treatment of Cutaneous T-Cell Lymphoma

Author： Vittorio C.C.   Rook A.H.   French L.E.   Shapiro M.   Lehrer M.S.   Junkinshopkins J.M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.7, 2001-07, pp. : 431-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Romidepsin in the Treatment of T-Cell Lymphoma†: Profile Report

By Yang Lily P.H.  

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 393-395

Adis International

Access to resources Recommend Favorite

Treatment of Cutaneous T Cell Lymphoma: Current Status and Future Directions

By Apisarnthanarax N.   Talpur R.   Duvic M.  

American Journal of Clinical Dermatology, Vol. 3, Iss. 3, 2002-03 ,pp. : 193-215

Adis International

Access to resources Recommend Favorite

Romidepsin: A Guide to its Clinical Use in Cutaneous T-Cell Lymphoma

By Lyseng-Williamson Katherine A.   Yang Lily P.H.  

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 67-71

Adis International

Access to resources Recommend Favorite

Management of Refractory Early-Stage Cutaneous T-Cell Lymphoma

By Huber Margit A.  

American Journal of Clinical Dermatology, Vol. 7, Iss. 3, 2006-01 ,pp. : 155-169

Adis International

Access to resources Recommend Favorite

Primary Cutaneous Small- to Medium-Sized CD4+ Pleomorphic T-Cell Lymphoma: A Retrospective Case Series and Review of the Provisional Cutaneous Lymphoma Category

By Williams Victoria L.  

American Journal of Clinical Dermatology, Vol. 12, Iss. 6, 2011-12 ,pp. : 389-401

Adis International

Access to resources Recommend Favorite